Ergoteles LLC Deciphera Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $216,583 - $260,291	16,309 New	16,309 $229,000
Q2 2022 Aug 12, 2022	BUY	$9.11 - $13.98 $114,786 - $176,148	12,600 Added 28.7%	56,500 $743,000
Q1 2022 May 13, 2022	BUY	$6.87 - $11.11 $219,207 - $354,497	31,908 Added 266.08%	43,900 $407,000
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $13,675 - $65,942	-1,776 Reduced 12.9%	11,992 $117,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $364,301 - $511,481	13,768 New	13,768 $468,000
Q4 2020 Feb 11, 2021	SELL	$51.77 - $66.18 $334,744 - $427,919	-6,466 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$43.8 - $58.16 $283,210 - $376,062	6,466 New	6,466 $332,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.